<DOC>
	<DOCNO>NCT01635985</DOCNO>
	<brief_summary>The purpose study look drug level AZD5423 blood drug administer different way - orally , intravenously inhale ( four different device ) , healthy subject</brief_summary>
	<brief_title>A Study Healthy Subjects Investigate Pharmacokinetics AZD5423 When Administered Different Ways</brief_title>
	<detailed_description>A Phase I , Single Centre , Open , Partly Randomised , Crossover Study Healthy Subjects Evaluate AZD5423 Absolute Pulmonary Bioavailability Administered Inhaled via New Dry Powder Inhaler , Turbuhaler , Spira nebulizer I-neb AAD system</detailed_description>
	<criteria>Healthy male woman nonchildbearing potential age 1845 year inclusive suitable vein cannulation repeat vein puncture Have body mass index ( BMI ) 19 30 kg/m2 ( inclusive rounding allow ) weight 50 100 kg ( inclusive ) Be able inhale inhaler device use study accord give instruction well able perform spirometry History clinically significant disease disorder Current smokers Any clinically relevant abnormal finding</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Phase I , Healthy male volunteer , pharmacokinetics</keyword>
</DOC>